TerrAscend Hits US$58.7 Million In Revenue, US$23.1 Million Net Loss In Q2 2021

TerrAscend Corp. (CSE: TER) reported today its Q2 2021 financial results, which saw the company post US$58.7 million in revenue. The topline figure is also an increase from Q1 2021’s revenue of US$53.4 million and Q2 2020’s revenue of US$34.2 million.

The cannabis firm relayed that the revenue growth is mainly driven by acquisitions, cultivation capacity expansions, and an increase in the number of dispensaries.

The company also recorded US$23.1 million net loss for the quarter, down from last quarter’s net loss of US$12.7 million and last year’s US$9.8 million net loss. This translates to US$0.14 loss per share.

Silver47 Exploration Inc. — sponsored Sponsored · Silver47 Exploration Inc.

The quarterly loss is mainly impacted by a loss on the fair value of warrants amounting to US$19.9 million. Considering this and a number of financial calibrations, adjusted EBITDA came in at $24.3 million compared to $22.6 million last quarter and $8.4 million last year.

The cash and cash equivalents balance at the quarter’s end came in at US$154.2 million compared to a beginning balance of US$59.2 million. The quarterly cash inflow is attributable to the $173.5 million net proceeds from private placement financing. This puts the company’s current asset balance to $254.2 million while current liabilities ended at $74.1 million.

The North American cannabis operator also announced that it is withdrawing its 2021 financial guidance due to a temporary reduction in yields caused by ongoing construction at its Pennsylvania locations. The company also considers allocating more company-branded products to its own Apothecarium dispensaries in New Jersey as another factor for withdrawing the guidance.

TerrAscend last traded at $10.75 on the CSE.


Information for this briefing was found via Sedar and the companies mentioned. The author has no securities or affiliations related to this organization unless otherwise mentioned. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Inside a Forgotten High-Grade Gold Mine in the Yukon | Blue Jay Gold [DD-on-the-GO Ep. 10]

WHICH MINING STOCKS CAN STILL RUN? | Mining Stock Mailbag [Nov. 9-13]

Silver’s Bull Market Isn’t Over | Peter Krauth

Recommended

Epic Gold Delivers Maiden 279,000 Ounce Inferred Resource at Wilson Project

First Phosphate Adds UK Export Finance to Growing Export Credit Lineup With C$220 Million Letter of Interest

Related News

TerrAscend Secures US$120 Million Term Loan To Fund Ilera Earn-Out Payment

TerrAscend Corp (CSE: TER) this morning announced that it has closed on a US$120 million...

Friday, December 18, 2020, 09:53:41 AM

TerrAscend Reports Preliminary Fourth Quarter Revenues Of $65.0 Million

It looks as if TerrAscend Corp (CSE: TER) is looking to stop the slow bleed...

Friday, February 19, 2021, 07:25:50 AM

TerrAscend To Begin Trading On The TSX On July 4

TerrAscend (CSE: TER) has “declared its independence” this morning, revealing to the market that it...

Thursday, June 29, 2023, 08:30:31 AM

TerrAscend Moves To Be First TSX-Listed US Cannabis Operator

TerrAscend Corp (CSE: TER) is moving to be one of the first cannabis issuers on...

Tuesday, March 14, 2023, 09:03:48 AM

Medipharm Labs and TerrAscend Corp Enter $27 Million Cannabis Distillate Agreement

Medipharm Labs (TSX: LABS) and TerrAscend Corp (CSE: TER) announced a significant transaction this morning,...

Wednesday, September 25, 2019, 08:56:45 AM